University of Birmingham, TikoMed's drug shows promise in ALS trial

Retrieved on: 2024-08-19 21:00:03

Tags for this article:

Orphan drugs

Clinical research

Drug discovery

ALS

Sodium phenylbutyrate

Clinical trial

Dextran

Click the tags to see associated articles and topics

University of Birmingham, TikoMed's drug shows promise in ALS trial. View article details on hiswai:

Excerpt

The gold standard of business intelligence. Find out more. This study was conducted at the University Hospitals Birmingham NHS Foundation Trust by ...

Article found on: www.clinicaltrialsarena.com

View Original Article